Regular check-ups allow healthcare providers to track progress, make any necessary adjustments, and address potential side effects early on
(16) studied 41 patients with GSSDs from 33 families and found that variants causing frameshift, premature-termination, or aberrant splicing were only observed in patients with moderate or severe clinical phenotypes
We can't stress this enough when you're delving into such intricate biological systems
Pharmacists and geneticists need closer collaboration to bridge the gap between clinical genomics and pharmacogenomics for safer medication use
A Phase 2 Study of OSI-906 (Linsitinib, an Insulin-Like Growth Factor Receptor-1 Inhibitor) in Patients With Asymptomatic or Mildly Symptomatic (Non-Opioid Requiring) Metastatic Castrate Resistant Prostate Cancer (CRPC)
#education #career #biotech --- For those entering the life science industry, seeking growth within, or simply aiming for a comprehensive understanding, dont miss out